Announced details
Biotechnology and healthcare, life sciences, regenerative medicine, clinical trials, manufacturing and marketing authorization in Europe, and international transportation and quality control of cell products
The company was selected to participate in the program. Capital ties, personnel ties, and existing business relationships are Not disclosed.
Operates NQ Global Startup Gateway, hosted by Osaka Prefecture. Based at Nakanoshima Qross, the program provides global and implementation-oriented development and co-creation opportunities for future medicine startups. Other information, including location, representative, capital, and year established, is Not disclosed.
Selection-based pitch event attended by 16 promising startups
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Official Nakanoshima Qross Innovation Challenge website (https://nq-gateway.jp/archives/542)
| Item | Details |
|---|---|
| Names of Products / Services Covered | Human (allogeneic) iPS cell-derived cardiac muscle cell sheets |
| Counterparty | Osaka Prefecture (program organizer) |
| Counterparty overview | Operates NQ Global Startup Gateway, hosted by Osaka Prefecture. Based at Nakanoshima Qross, the program provides global and implementation-oriented development and co-creation opportunities for future medicine startups. Other information, including location, representative, capital, and year established, is Not disclosed. |
| Relationship with the Company | The company was selected to participate in the program. Capital ties, personnel ties, and existing business relationships are Not disclosed. |
| Applicable area | Biotechnology and healthcare, life sciences, regenerative medicine, clinical trials, manufacturing and marketing authorization in Europe, and international transportation and quality control of cell products |
| Location scale | Selection-based pitch event attended by 16 promising startups |
| Source | Official Nakanoshima Qross Innovation Challenge website (https://nq-gateway.jp/archives/542) |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Following the selection process, the company was selected to participate in the program providing access to the UK ecosystem. The company believes this reflects the high evaluation of its technology platform and business potential within the healthcare industry ecosystem.